ContractStock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionSTOCK OPTION AGREEMENT, made as of the 10th day of June, 2016, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Optionee”).
STOCK OPTION AGREEMENT, made as of the 29th day of October, 2018, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and Mark weinreb (the “Optionee”). WHEREAS, the Optionee serves as the Chief Executive Officer and...Stock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionWHEREAS, the Company and the Optionee are parties to an Executive Employment Agreement dated as of March 9, 2015, as amended (the “Employment Agreement”); and
ContractStock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionSTOCK OPTION AGREEMENT, made as of the 29th day of October, 2018, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ______________ (the “Optionee”).
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Amended and Restated Executive Employment Agreement, dated as of May 10, 2011, between BioRestorative Therapies, Inc. (formerly known as Stem Cell Assurance, Inc.) and Francisco Silva, as amended (the “Employment Agreement”).
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Executive Employment Agreement, dated as of March 9, 2015, between BioRestorative Therapies, Inc. (the “Company”) and you (the “Executive”), as amended (the “Employment Agreement”). All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Employment Agreement.
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Executive Employment Agreement, dated as of September 2, 2015, between BioRestorative Therapies, Inc. (the “Company”) and you (the “Executive”) as amended (the “Employment Agreement”). All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Employment Agreement.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made as of September 2, 2015 by and between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Executive”). Certain capitalized terms used in this Agreement are defined in Section 11.
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Executive Employment Agreement, dated as of September 2, 2015, between BioRestorative Therapies, Inc. (the “Company”) and you (the “Executive”) as amended (the “Employment Agreement”). All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Employment Agreement.
ContractStock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionSTOCK OPTION AGREEMENT, made as of the 12th day of July, 2017, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Optionee”).
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Executive Employment Agreement, dated as of September 2, 2015, between BioRestorative Therapies, Inc. (the “Company”) and you (the “Executive”) (the “Employment Agreement”). All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Employment Agreement.
BioRestorative Therapies, Inc.Executive Employment Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 29th, 2019 Company IndustryReference is made to the Executive Employment Agreement, dated as of May 10, 2011, between BioRestorative Therapies, Inc. (the “Company”) and you (the “Executive”), as amended (the “Employment Agreement”). All capitalized terms used and not defined herein shall have the meanings ascribed to them in the Employment Agreement.
ContractStock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionSTOCK OPTION AGREEMENT, made as of the 13th day of August, 2015, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Optionee”).
ContractStock Option Agreement • March 29th, 2019 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec • Delaware
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionSTOCK OPTION AGREEMENT, made as of the 29th day of October, 2018, between BIORESTORATIVE THERAPIES, INC., a Delaware corporation (the “Company”), and ROBERT PACCASASSI (the “Optionee”).